Trials / Unknown
UnknownNCT02205580
Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Tonsillectomy or Adeno-tonsillectomy in Children
Comparison of Three Different Rates of Continuous Intravenous Sufentanil Infusion for Postoperative Pain Management Following Coblation Tonsillectomy or Adeno-tonsillectomy in Children
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Jin Ni · Academic / Other
- Sex
- All
- Age
- 5 Years – 8 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative pain following tonsillectomy or adeno-tonsillectomy in children is severe and sometimes last for days. Sufentanil is used by epidural route for postoperative analgesia in children. There are few reports about its use for postoperative analgesia by continuous intravenous infusion. Its complications include , hypoxia, sedation, pruritus ,nausea and/or vomiting. The investigators design this protocol to test efficacy of analgesia of three different rates of continuous intravenous sufentanil infusion for postoperative pain management following coblation tonsillectomy or adeno-tonsillectomy in children. The investigators also compare incidence rate of complications for three groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | continuous intravenous sufentanil 0.02μg•kg-1•h-1 infusion | |
| DRUG | continuous intravenous sufentanil 0.03μg•kg-1•h-1 infusion | |
| DRUG | continuous intravenous sufentanil 0.04μg•kg-1•h-1 infusion |
Timeline
- Start date
- 2014-09-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2014-07-31
- Last updated
- 2014-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02205580. Inclusion in this directory is not an endorsement.